Genetic Testing in Guiding Treatment for Patients With Brain Metastases

NCT03994796 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

CDK Gene Mutation
Metastatic Malignant Neoplasm in the Brain
Metastatic Malignant Solid Neoplasm
NTRK Family Gene Mutation
PI3K Gene Mutation
ROS1 Gene Mutation
KRAS G12C Mutation

Interventions

DRUG: Abemaciclib
DRUG: PI3K Inhibitor paxalisib
DRUG: Entrectinib
DRUG: Adagrasib

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]